Cite
HARVARD Citation
Wilfret, D. et al. (n.d.). A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects. Clinical pharmacology in drug development. 3 (6), pp. 439-448. [Online].